Optimal risk thresholds for prescribing statins as primary prevention of cardiovascular disease in Iranian general population : a benefit-harm modelling study
| dc.contributor.author | Khalili, Davood | |
| dc.contributor.author | Saadati, Hassan | |
| dc.contributor.author | Baradaran, Hamid Reza | |
| dc.contributor.author | Hadaegh, Farzad | |
| dc.contributor.author | Steyerberg, Ewout W | |
| dc.contributor.author | Woodward, Mark | |
| dc.contributor.author | Danaei, Goodarz | |
| dc.contributor.institution | University of Aberdeen.Institute of Applied Health Sciences | en |
| dc.contributor.institution | University of Aberdeen.Other Applied Health Sciences | en |
| dc.date.accessioned | 2024-11-06T13:58:01Z | |
| dc.date.available | 2024-11-06T13:58:01Z | |
| dc.date.issued | 2024-10-18 | |
| dc.description.status | Peer reviewed | en |
| dc.format.extent | 11 | |
| dc.format.extent | 1189894 | |
| dc.identifier | 298146045 | |
| dc.identifier | 9eaa41d0-aff4-4ada-90f3-e3b8dba65cac | |
| dc.identifier | 39425029 | |
| dc.identifier | 85206586732 | |
| dc.identifier.citation | Khalili, D, Saadati, H, Baradaran, H R, Hadaegh, F, Steyerberg, E W, Woodward, M & Danaei, G 2024, 'Optimal risk thresholds for prescribing statins as primary prevention of cardiovascular disease in Iranian general population : a benefit-harm modelling study', BMC Cardiovascular Disorders, vol. 24, 575. https://doi.org/10.1186/s12872-024-04242-x | en |
| dc.identifier.doi | 10.1186/s12872-024-04242-x | |
| dc.identifier.issn | 1471-2261 | |
| dc.identifier.other | ORCID: /0000-0002-5070-5864/work/171447404 | |
| dc.identifier.uri | https://hdl.handle.net/2164/24567 | |
| dc.identifier.vol | 24 | en |
| dc.language.iso | eng | |
| dc.relation.ispartof | BMC Cardiovascular Disorders | en |
| dc.subject | SDG 3 - Good Health and Well-being | en |
| dc.subject | Humans | en |
| dc.subject | Middle Aged | en |
| dc.subject | Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use | en |
| dc.subject | Male | en |
| dc.subject | Female | en |
| dc.subject | Iran/epidemiology | en |
| dc.subject | Adult | en |
| dc.subject | Aged | en |
| dc.subject | Cardiovascular Diseases/prevention & control | en |
| dc.subject | Primary Prevention | en |
| dc.subject | Risk Assessment | en |
| dc.subject | Treatment Outcome | en |
| dc.subject | Age Factors | en |
| dc.subject | Sex Factors | en |
| dc.subject | Drug Prescriptions | en |
| dc.subject | Heart Disease Risk Factors | en |
| dc.subject | Decision Support Techniques | en |
| dc.subject | Clinical Decision-Making | en |
| dc.subject | Time Factors | en |
| dc.subject | Practice Patterns, Physicians' | en |
| dc.subject | R Medicine (General) | en |
| dc.subject.lcc | R1 | en |
| dc.title | Optimal risk thresholds for prescribing statins as primary prevention of cardiovascular disease in Iranian general population : a benefit-harm modelling study | en |
| dc.type | Journal article | en |
Files
Original bundle
1 - 1 of 1
- Name:
- Khalili_etal_BMCCD_Optimal_Risk_Thresholds_VOR.pdf
- Size:
- 1.13 MB
- Format:
- Adobe Portable Document Format
